A single stem cell has the potential to generate an animal made of millions of different types of cells. Some cancers contain stem-like but abnormal cells that can act like mini factories to rapidly churn out not only more ...
Sep 10, 2015
0
161
(HealthDay)—Biomarkers can be used to guide decisions on systemic therapy for women with metastatic breast cancer, according to the American Society of Clinical Oncology Clinical Practice Guideline published online July ...
Jul 21, 2015
0
11
Despite advances in managing and curing some forms of breast cancer, women whose disease becomes metastatic have fewer effective options. A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant ...
Jun 1, 2015
0
15
Promising advances in research could mean longer, healthier lives for women with breast cancer, the number one cancer in women worldwide, experts said Saturday at a major US cancer conference.
May 31, 2015
0
108
Pfizer's new targeted drug, palbociclib, has been shown to halt the progression of the most common form of advanced breast cancer in women, researchers said Saturday.
May 30, 2015
0
140
For more than three decades, no new drug for the treatment of breast cancer has been presented. A group of researchers analyzing a marine sponge called Halichondrin okadai obtained a mesylate eribulin substance that had already ...
May 5, 2015
0
20
Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer ...
Feb 20, 2015
0
18
Results from the final analysis of progression-free survival, response rate, and safety for the randomized, phase III Breast Cancer Trials of Oral Everolimus-1 (BOLERO-1) are to be presented here at the 2014 San Antonio Breast ...
Dec 15, 2014
0
0
A newly-identified genetic mutation could increase our understanding of how breast cancer spreads and potentially guide treatment options for women with the disease, according to a study from Magee-Womens Research Institute ...
Dec 12, 2014
1
0
A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) ...
Dec 10, 2014
0
0
